SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
8.55
+0.21 (2.52%)
Apr 29, 2026, 12:29 PM EDT - Market open
SciSparc Revenue
SciSparc had revenue of $1.31M in the twelve months ending September 30, 2025, up 187.98% year-over-year. In the year 2024, SciSparc had annual revenue of $1.31M, down -54.64%.
Revenue (ttm)
$1.31M
Revenue Growth
+187.98%
P/S Ratio
3.61
Revenue / Employee
$653,000
Employees
2
Market Cap
4.84M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| 60 Degrees Pharmaceuticals | 1.41M |
| Bio Green Med Solution | 747.00K |
| VivoSim Labs | 142.00K |
| AIM ImmunoTech | 88.00K |
| Cardio Diagnostics Holdings | 14.83K |
| Azitra | 7.50K |
| Pulmatrix | 3.00K |
| Soligenix | 2.34K |
SPRC News
- 5 days ago - Neurothera Labs Engages bullVestor for Investor Relations Activities - TheNewswire
- 6 weeks ago - SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy - GlobeNewsWire
- 6 weeks ago - SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease - GlobeNewsWire
- 7 weeks ago - SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails - GlobeNewsWire
- 7 weeks ago - Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease - GlobeNewsWire
- 7 weeks ago - Neurothera Labs Inc. Announces Definitive Agreement To Acquire Majority Stake In Cliniquantum Ltd. - TheNewswire
- 2 months ago - SciSparc Announces 1-for-9 Reverse Share Split - GlobeNewsWire
- 3 months ago - SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA - GlobeNewsWire